ChemaTox Laboratory is a valuable team member in pain management. The information provided by medication monitoring testing is an important tool for a patient’s medical team in evaluating patient compliance with prescription therapy.
The major drugs that are available for pain management have limitations and have a high potential for abuse or misuse. Clinical guidelines have been published to assist providers in managing the treatment of patients with chronic non-cancer pain. There are state and federal guidelines in addition to clinical guidelines.
A pain management plan may include personal and family medical histories, screening surveys and/or treatment agreements with patients. The patient information provided to the laboratory is important to assisting interpretation of test results.
ChemaTox provides pain therapy specimen testing for drugs and their metabolites principally in urine. While specimen screening is normally performed using urine, ChemaTox will perform this testing on blood samples if arranged in advance. Qualitative testing is performed utilizing test methods with the highest sensitivity such as Gas Chromatography/ Mass Spectroscopy (GC/MS) and Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS). This high complexity testing has high accuracy and low limits of detection.
6-MAM (Heroin Metabolite)